Virus News and Research

Latest Virus News and Research

A review of innate immunity relevant to SARS-CoV-2 and COVID-19

In a recent study published in The New England Journal of Medicine, researchers reviewed selected acute-phase proteins concerning their production, structure, and function.

7 Feb 2023

Understanding the relationship between SARS-CoV-2 infection and periodontitis

In a recent review published in the journal International Journal of Molecular Sciences, researchers reviewed existing data on the association between periodontitis and coronavirus disease 2019 (COVID-19).

7 Feb 2023

Mucoactive drugs block SARS-CoV-2 infection

Researchers evaluate the effects of mucociliary active molecules on SARS-CoV-2 infection in vitro.

7 Feb 2023

Study reports two cases of ocular MPox in HIV-infected patients

Researchers review the symptoms, diagnosis, and treatment of ocular Mpox syndrome in men living with HIV infection.

7 Feb 2023

Study characterizes mutations in neuraminidase of human-like H5N1 influenza viruses

A study published in PLOS PATHOGENS describes the prevalence and functions of mutations in neuraminidase enzyme of avian H5N1 influenza viruses that are preferentially selected in human H5N1 influenza viruses.

7 Feb 2023

The nature of the immune responses induced by various COVID-19 vaccines developed using different platforms and formulations

Researchers reviewed existing achievements and shortcomings in SARS-CoV-2 vaccine platforms, as well as future-generation vaccine considerations.

7 Feb 2023

The safety profile and the actual known adverse effects of COVID-19 vaccines in at-risk and healthy individuals

Researchers discussed the safety of COVID-19 vaccines in healthy people and patients with autoimmunity or cardiac issues.

7 Feb 2023

A secret weapon in preventing the next pandemic: Fruit bats

More than four dozen Jamaican fruit bats destined for a lab in Bozeman, Montana, are set to become part of an experiment with an ambitious goal: predicting the next global pandemic.

7 Feb 2023

New recommendations for optimization, validation of the quantitative measurement of HBV cccDNA

Approximately 300 million people worldwide are chronically infected with the hepatitis B virus (HBV) and at high risk of developing liver cirrhosis or hepatocellular carcinoma.

6 Feb 2023

Large study on post-COVID dysosmia and dysgeusia

In a new study posted to the medRxiv* preprint server, scientists in the United States assessed the extent of post-COVID-19 olfactory and gustatory dysfunction to gain deeper insights into the quality and severity of the symptoms over a year.

6 Feb 2023

9 out of every 10 people hospitalized with the flu have at least one underlying medical condition

Leading health organizations are urging people to get a flu shot if they haven't already done so. Compared to last year's mild flu season, the U.S. has already seen more than three times the number of flu-related deaths.

6 Feb 2023

Cancer-causing viruses use a human protein to evade the innate immune response

The viruses Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) have been linked to several cancers.

6 Feb 2023

Urine-diverting toilets can reduce a person’s exposure to virus particles

Parents often give their children useful advice: Wash your hands, cover your cough and put the toilet lid down before flushing.

6 Feb 2023

New research may explain why some patients suffer from long-COVID

A review article published in The Journal of Clinical Investigation deciphers the relationship between rare inborn errors of type I interferon immunity and the development of severe coronavirus disease 2019 (COVID-19) pneumonia.

6 Feb 2023

A novel multiplexed assay to diagnose Mpox and other viruses

Researchers evaluate the performance of novel assay to identify Mpox viral infection.

6 Feb 2023

AAHI awarded a $9.9 million project to develop prototype intranasal bivalent influenza RNA vaccine candidate

The Access to Advanced Health Institute announced today that it has been awarded a project agreement worth up to $9.9 million through the Medical CBRN Defense Consortium Other Transaction Authority to develop a prototype intranasal bivalent influenza RNA vaccine candidate based on AAHI's self-amplifying RNA (saRNA) platform that targets both pandemic A(H5N1) and A(H7N9) influenza virus pathogens.

6 Feb 2023

New method for ultra-fast detection of coronavirus using nanosensors

The ability of gold particles to reflect light in different colors is used in applications from stained glass to pregnancy tests.

6 Feb 2023

A technicality could keep RSV shots from kids in need

After more than five decades of trying, the drug industry is on the verge of providing effective immunizations against the respiratory syncytial virus, which has put an estimated 90,000 U.S. infants and small children in the hospital since the start of October.

6 Feb 2023

How did mental health outcomes in the Italian general population change 14 months into the COVID-19 pandemic?

Researchers from Italy investigated the change in mental health outcomes such as anxiety, depression, and stress-related problems among the general population 14 months after the onset of the COVID-19 pandemic.

6 Feb 2023

Virus Watch: A cohort study of COVID-19 in households of England and Wales

A new study posted on the pre-print medRxiv* aimed to discuss how Virus Watch provided public health approaches that were effective for the investigation of community incidence, symptom profiles, and the transmission of COVID-19, as well as the effectiveness of the COVID-19 vaccines.

5 Feb 2023